Federal Reserve Chairwoman Janet Yellen and New York Fed President William Dudley said the central bank could boost interest rates as soon as next month, while Fed Vice Chairman Stanley Fischer voiced confidence that inflation isn’t too far below the goal.
Keystone XL has become one of the most contentious energy issues of Barack Obama’s presidency, and the pause would allow him to put off a tough decision on an issue that has divided key Democratic constituencies.
A bipartisan movement to cut prison sentences for nonviolent drug crimes and make it easier for ex-offenders to find employment could get caught up it presidential politics.
Pierre Garcon, who now plays for the Washington Redskins, and his lawyers accused the Manhattan-based FanDuel of exploiting him and other National Football League players to grow its business.
Slipping enrollment has done little to shake the faith that the nation's biggest health insurers, including Anthem, have placed in the Affordable Care Act's public insurance exchanges.
Jeff Simmons is on a counteroffensive as, increasingly, the drugs that Elanco makes—including antibiotics and productivity enhancers—have come under attack by food activists.
Shares in Anthem Inc., the nation's third-largest health insurer by market value, dropped Wednesday after the company’s 2015 profit outlook fell short of estimates.
The regulatory package known as the Clean Power Plan officially became U.S. law Friday. It was immediately challenged by 24 states in a U.S. appeals court filing that included Indiana.
The U.S. owns nearly 80 percent of Fannie Mae and Freddie Mac, and investors have been pressing the administration to unwind a 2012 decision to sweep their profits to the Treasury Department.
Shares in Anthem Inc. and Cigna Corp., which agreed to a $48 billion deal in July, continued to slide Thursday after presidential candidate Hillary Clinton said mergers in the industry deserve more scrutiny.
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
The lawsuit asks the court to clarify 1970s-era rules that prevent borrowers from getting rid of education debt in bankruptcy, except in cases in which repaying it would constitute an “undue hardship.”
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Southwest Airlines Co. said it has fixed computer system failures that delayed hundreds of flights around the United States over the weekend.
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
President Barack Obama needs to hold together a razor-thin majority of pro-trade lawmakers in the U.S. Congress to win approval of his huge Asia-Pacific trade deal.
Indianapolis-based Republic has been unable to fulfill an unspecified number of flights for Delta’s regional operation, Delta Connection, according to the suit filed Monday.
Building or investing in sports facilities in order to boost finances at a university is nearly always a losing play, according to financial experts.
College athletes are heading back to court in pursuit of pay for play one day after a major setback in their quest for a larger share of the multibillion-dollar industry.
